Dr. Kimberly Chan, MD

Dr. Chan practices at Chan United Medical Group, Inc. in Alhambra, California.

Dr. Chan's NPI, 1295166692, was assigned on December 10, 2013. Dr. Chan graduated from University Institute of Medicine 1 in 1999. Dr. Chan holds California license A127955.

Dr. Chan's primary practice is Chan United Medical Group, Inc., at 1001 S Garfield Ave, Alhambra, CA 91801 in Los Angeles County. The practice phone is (626) 308-0138.

Dr. Chan's primary practice is Chan United Medical Group, Inc. in Alhambra, California. The medical group on file is Wong Shi-Yin MD. Dmand AI also links Dr. Chan to 2 more group practices and clinics, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chan is licensed in California.

Dmand AI lists aneurysm, arthritis, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension, chronic kidney disease and chronic obstructive pulmonary disease (COPD) among the conditions Dr. Chan treats.

CMS data shows 14,557 Medicare services from Dr. Chan across 16 procedure codes in 2024, for 301 Medicare patients. Medicare paid $585,929 for them. Every service was in an office.

CMS counts 301 Medicare patients who saw Dr. Chan in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 89% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 68, with 60% women.

In 2024, Dr. Chan wrote 12,982 Medicare Part D claims for 709 patients. 82% of them were for generic drugs. CMS names the drug for 12,440 of them, across 150 drugs with 11 or more claims each, at $1,596,404 in total drug cost. In 2023, CMS named 11,925 claims across 142 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Chan for performance year 2024, reported individually. Dr. Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chan as offering telehealth.

CMS Open Payments shows 104 general payments to Dr. Chan from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $504.

Dr. Chan graduated from University Institute of Medicine 1 in 1999.

Dr. Chan is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and LA Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.